Detection of apoptosis and expression of apoptosis-associated proteins as early predictors of prognosis after irradiation therapy in stage IIIb uterine cervical cancer

Japanese Journal of Cancer Research

Volumn 91, Issue 1, 2000, Pages 127-134

  Yuki, Hiroyoshi ^a   Fujimura, Masaki ^b   Yamakawa, Yoshihiro ^b   Hidaka, Takao ^b   Saito, Shigeru ^b  

^a TONAMI GENERAL HOSPITAL   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Apoptosis; Irradiation therapy; Prediction of prognosis; Uterine cervical cancer

Indexed keywords

CASPASE 3; CELL PROTEIN; INTERLEUKIN 1BETA CONVERTING ENZYME; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL TIME; UTERINE CERVIX CANCER;

EID: 0034058788     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2000.tb00869.x     Document Type: Article

References (38)

1. Stehman, F. B., Perez, C. A., Kurman, R. J. and Thigpen, J. T. Uterine cervix. In "Principles and Practice of Gynecologic Oncology," ed. W. J. Hoskins, C. A. Perez and R. C. Young, pp.785-857 (1997). Lippincott-Raven, Philadelphia.
2. Levine, E. L., Renehan, R., Gossiel, S. E., Davidson, S. A., Chadwick, R. C., Wilks, D. P., Potten, C. S., Hendry, J. H., Hunter, R. D. and West, C. M. L. Apoptosis, intrinsic radiosensitivity and prediction of radiotherapy response in cervical carcinoma. Radiother. Oncol., 37, 1-9 (1995).
3. Kerr, J. F. R., Winterford, C. M. and Harmon, B. V. Apoptosis: its significance in cancer and cancer therapy. Cancer, 73, 2013-2026 (1994).
4. Radford, I. R. and Murphy, T. K. Radiation response of mouse lymphoid and myeloid cell lines. Part III. Different signals can lead to apoptosis and may influence sensitivity to killing by DNA double strand breakage. Int. J. Radiat. Oncol. Biol. Phys., 65, 229-239 (1994).
5. Hopcia, K. L., McCarey, Y. L., Sylvester, C. and Held, K. D. Radiation-induced apoptosis in HL60 cells: oxygen effect, relationship between apoptosis and loss of clonogenicity, and dependence of time to apoptosis on radiation dose. Radiat. Res., 145, 315-323 (1996).
6. Stephans, L. C., Ang, K. K., Schultheiss, T. E., Milas, L. and Meyn, R. E. Apoptosis in irradiated murine tumors. Radiat. Res., 127, 308-316 (1991).
7. Levine, E. L., Davidson, S. E., Roberts, S. A., Chadwick, C. A., Potten, C. S. and West, C. M. L. Apoptosis as predictor of response to radiotherapy in cervical carcinoma. Lancet, 344, 472 (1994).
8. Harn, H. J., Hsieh, H. F., Ho, L. I., Yu, C. P., Chen, J. H., Chiu, C. C., Fan, H. C. and Lee, W. H. Apoptosis in nasopharyngeal carcinoma as related to histopathological characteristics and clinical stage. Histopathology, 33, 117-122 (1998).
9. Kraxner, H., Tamas, L., Jaray, B., Ribari, O., Szentirmay, Z. and Szende, B. Search for prognostic factors in head and neck cancer. Acta Otolaryngol. (Stockh.), 527, 145-149 (1997).
10. Ohno, T., Nakano, T., Niibe, Y., Tujii, H. and Oka, K. Bax protein expression correlates with radiation-induced apoptosis in radiation therapy for cervical carcinoma. Cancer, 83, 103-110 (1998).
11. Tsujimoto, Y. Apoptosis and necrosis: intracellular ATP level as a determinant for cell death modes. Cell Death Differ., 4, 429-434 (1997).
12. Simosato Y., Oboshi, S. and Baba, K. Histological evaluation of effects of radiotherapy and chemotherapy for carcinomas. Jpn. J. Clin. Oncol., 1, 19-35 (1971).
13. Ueda, M., Ueki, K., Kumagai, K., Terai, Y., Kanemura, M. and Ueki, M. Neoadjuvant intra-arterial infusion chemotherapy induced apoptotic cell death in locally advanced uterine cervical carcinomas. A preliminary report. Int. J. Gynecol. Cancer, 8, 144-149 (1998).
14. Saegusa, M., Takano, Y., Hashimura, M., Shoji, Y. and Okayasu, I. The possible role of bcl-2 expression in the progression of tumors of the uterine cervix. Cancer, 76, 2297-2303 (1995).
15. Tjalma, W., De Cuyper, E., Weyler, J., VanMarck, E., De Pooter, C., Albertyn, G. and van Dam, P. Expression of bcl-2 in invasive and in situ carcinoma of the uterine cervix. Am. J. Obstet. Gynecol., 178, 113-117 (1998).
16. Chhanabhai, M., Krajewski, S., Krajewska, M., Wang, H.-G., Reed, J. C. and Gascoyne, R. D. Immunohistochemical analysis of interleukin-1β-converting enzyme/Ced-3 family protease, CPP32/Yama/Caspase-3, in Hodgkin's disease. Blood, 90, 2451-2455 (1997).
17. Lutgens, L. C., Schuttle, B., de Jong, J. M. and Thunnissen, F. B. DNA content as prognostic factor in cervix carcinoma stage IB-III treated with radiotherapy. Gynecol. Oncol., 54, 275-281 (1994).
18. Perez, C. A., Grigsby, P. W., Nene, S. M., Camel, H. M., Galakatos, A., Kao, M. S. and Lockett, M. A. Effect of tumor size on the prognosis of carcinoma of the uterine cervix treated with irradiation alone. Cancer, 69, 2796-2806 (1992).
19. Grigsby, P. W., Perez, C. A., Kuske, R. R., Camel, H. M., Kao, M. S., Galakatos, A. E. and Hederman, M. A. Adenocarcinoma of the uterine cervix: lack of evidence for a poor prognosis. Radiother. Oncol., 12, 289-296 (1988).
20. Masuda, M., Takano, Y., Iki, M., Asakura, T., Hashiba, T., Noguchi, S. and Hosaka, M. Apoptosis in transitional cell carcinoma of the renal pelvis and ureter: association with proliferative activity, bcl-2 expression and prognosis. J. Urol., 158, 750-753 (1997).
21. Korkolopoulou, P., Angelopoulou, M. K., Kontopidou, F., Tsenga, A., Patsouris, E., Tsagli, E. T., Kittas, C. and Pangalis, G. A. Prognostic relevance of apoptotic cell death in non Hodgkin's lymphomas: a multivariate survival analysis including Ki67 and p53 oncoprotein expression. Histopathology, 33, 240-247 (1998).
22. Sakuragi, N., Ohkouchi, T., Hareyama, H., Ikeda, K., Watari, H., Fujimoto, T., Kuwabara, M., Yamamoto, R., Sagawa, T., Fujino, T. and Fujimoto, S. Bcl-2 expression and prognosis of patients with endometrial carcinoma. Int. J. Cancer, 79, 153-158 (1998).
23. Zang, G., Kimijima, I., Watanabe, T., Kanno, M., Sagara, H., Furukawa, Y., Tuchiya, A. and Abe, R. Correlation between apoptotic index: Bcl-2 protein expression and progression and prognosis in breast carcinoma. Jpn. J. Cancer Chemother., 25, 415-421 (1998).
24. Wheeeler, J. A., Stephens, L. C., Tornos, C., Eifel, P. J., Kian Ang, K., Milas, L., Allen, P. K. and Meyn, R. E., Jr. Apoptosis as a predictor of tumor response to radiation in stage 1b cervical carcinoma. Int. J. Radiat. Oncol. Biol. Phys., 32, 1487-1493 (1995).
25. Cuello-Carrion, F. D. and Ciocca, D. R. Improved detection of apoptotic cells using a modified in situ TUNEL technique. J. Histochem. Cytochcem., 47, 837-839 (1999).
26. Krajewska, M., Wag, H. G., Krajewski, S., Zapata, J. M., Shabaik, A., Gascoyne, R. and Reed, J. C. Immunohistochemical analysis of in vivo patterns of expression of CPP32 (caspase-3), a cell death protease. Cancer Res., 57, 1605-1613 (1997).
27. Arai, M. Expression of caspase-1, -2, -3 in human astrocytic tumors. J. Juzen Med. Soc., 107, 87-94 (1998).
28. Harima, Y., Harima, K., Shikata, N., Oka, A., Ohnishi, T. and Tanaka, Y. Bax and Bcl-2 expressions predict response to radiotherapy in human cervical cancer. Cancer Res. Clin. Oncol., 124, 503-510 (1998).
29. Pereira, H., Silva, S., Juliao, R., Garcia, P. and Perpetua, F. Prognostic markers for colorectal cancer: expression of p53 and Bcl-2. World J. Surg., 21, 210-213 (1997).
30. Ishioka, C., Osada, M., Gamo, M. and Kanamaru, R. p53 as a molecular target for cancer therapy. Jpn. J. Cancer Chemother., 24, 2207-2212 (1997).
31. Mitsuhayashi, N., Takahashi, T., Sakurai, H., Nozaki, M., Akimoto, T., Hasegawa, M., Saito, Y., Matsumoto, H., Higuchi, K., Maebayashi, K. and Niibe, H. A radioresistant variant cell line, NMT-1R, isolated from a radiosensitive rat yolk sac tumour cell line, NMT-1: differences of early radiation-induced morphological changes, especially apoptosis. Int. J. Radiat. Biol., 69, 329-336 (1996).
32. Ngan, H. Y., Tsao, S. W., Liu, S. S. and Stanley, M. Abnormal expression and mutation of p53 in cervical cancer - a study at protein, RNA and DNA levels. Genitourin. Med., 73, 54-58 (1997).
33. Krajewska, M., Preiser, C. M., Krajewski, S., Song, K., Macdonald, J. S., Stemmerman, G. and Reed, J. C. Immunohistochemical analysis of bcl-2 family protein in adenocarcinomas of the stomach. Am. J. Pathol., 149, 1449-1457 (1996).
34. Krajewska, M., Krajewski, S., Epstein, J. I., Shabaik, A., Sauvageot, J., Song, K., Kitada, S. and Reed, J. C. Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcI-1 expression in prostate cancers. Am. J. Pathol., 148, 1567-1576 (1996).
35. Keys, H. M., Bundy, B. N., Stehman, F. B., Muderspach, L. I., Chafe, W. E., Suggs, C. L., III, Walker, J. L. and Gersell, D. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervival carcinoma. N. Engl. J. Med., 340, 1154-1164 (1999).
36. Rose, P. G., Bundy, B. N., Watkins, E. B., Thigpen, J. T., Deppe, G., Maiman, M. A., Clarke-Pearson, D. L. and Insalaco, S. Concomitant cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N. Engl. J. Med., 340, 1144-1153 (1999).
37. Morris, M., Eifel, P. J., Lu, J., Grigsby, P. W., Levenback, C., Stevens, R. E., Rotman, M., Gershenson, D. M. and Mutch, D. G. Pelvic radiation with concomitant chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N. Engl. J. Med., 340, 1137-1143 (1999).
38. Thomas, G., Dembo, A., Ackerman, I., Franssen, E., Balogh, J., Fyles, A. and Levin, W. A randomized trial of standard versus partially hyperfractionated radiation with or without concomitant 5-fluorouracil in locally advanced cervical cancer. Gynecol. Oncol., 69, 137-145 (1998).